The results are consistent with a previous study reporting that TGFBI is a favorable prognostic factor for survival in patients with squamous cell lung cancer treated with adjuvant platinum-based chemotherapy29. The gene discussed is TGFBI; the disease is squamous cell lung carcinoma.